LOADING
Comparing Microsoft Corporation (MSFT) and Johnson & Johnson (JNJ) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | JNJ |
|---|---|---|
| Price | $373.46 | $243.04 |
| Change Today | +1.11% | -0.44% |
| Market Cap | $2.75T | $585.7B |
| P/E Ratio | 23.1 | 22.0 |
| Forward P/E | 19.4 | 21.1 |
| PEG Ratio | 1.21 | 1.71 |
| EPS | $15.99 | $11.03 |
| Revenue Growth (YoY) | 16.7% | 9.1% |
| Profit Margin | 39.0% | 28.5% |
| Return on Equity | 34.4% | 35.0% |
| Dividend Yield | 0.94% | 2.11% |
| Beta | 1.11 | 0.33 |
| 52-Week High | $552.24 | $251.71 |
| 52-Week Low | $342.17 | $137.67 |
| Volume | 24.1M | 6.9M |
Microsoft Corporation is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.